Internally Calibrated Chromatin Immunoprecipitation Using Barcoded Nucleosomes
使用条形码核小体进行内部校准染色质免疫沉淀
基本信息
- 批准号:9045474
- 负责人:
- 金额:$ 67.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-15 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAlgorithmsAntibodiesAreaBiological AssayCalibrationCellsChicagoChromatinCore FacilityDNADNA SequenceDataData SetDevelopmentDiagnosticEnzymesEpigenetic ProcessEvaluationExhibitsGene ExpressionGenomic SegmentGenomicsHistonesImmunoprecipitationLettersLicensingLysineMalignant NeoplasmsMethodsMolecularNoiseNuclear ExtractNucleic AcidsNucleosomesPaperPhasePost-Translational Protein ProcessingReactionReadingReagentReportingReproducibilityResearchResearch InstituteResearch PersonnelSamplingSignal TransductionSiteSourceUniversitiesValidationanalytical methodassay developmentbasechromatin immunoprecipitationchromatin proteinclinical applicationcommercializationdensityepigenetic regulationexperienceimprovedin vivointerestnext generation sequencingnovel therapeuticspublic health relevancereconstitutionresearch study
项目摘要
DESCRIPTION (provided by applicant): Chromatin immunoprecipitation (ChIP) is one of the core methods in the study of epigenetic regulation of gene expression. Analytical methods, such as qPCR, microarray and next generation sequencing (NGS) have increased throughput, but not the reliability of ChIP datasets. Using state-of-the-art reagents, ChIP is at best semi-quantitative, and at worst unrepresentative of in vivo post-translational modification (PTM) density. To address this short-coming, EpiCypher, Inc. has partnered with Dr. Alex Ruthenburg of the University of Chicago who has pioneered a method to internally-standardize ChIP experiments for subsequent normalization and quantitation of epigenetic marks. The method, referred to here as Internally Calibrated Immunoprecipitation Sequencing, or ICeChIP-Seq, was recently licensed on an exclusive basis by EpiCypher, Inc. and relies on designer nucleosomes collaboratively developed and manufactured by EpiCypher and the Ruthenburg lab. These nucleosomes are modified with an epigenetic mark of interest and wrapped in a DNA sequence containing a unique, identifying barcode sequence. Barcoded designer nucleosomes are added to the ChIP reaction at various concentrations, containing purified chromatin and a bead-attached pull-down antibody against the epigenetic mark of interest. After immunoprecipitation, next generation sequencing data is analyzed for the number of reads detected for 1) each barcode and 2) immunoprecipitated input DNA with the resulting ratio used to compute IP enrichment quantitatively. Read number can then be normalized to input concentration for each barcoded nucleosome, providing a standard curve for quantitation of sample DNA reads. The barcoded nucleosomes serve as calibrators because they are subjected to the same sources of variability the sample chromatin experiences during the ChIP reaction, and they precisely resemble the target of the IP. Proof-of-concept development of the assay has focused on the following: synthesis of barcoded nucleosomes; analysis of their quality; development of an H3K4me3 assay; analysis algorithms; characterizing signal-to-noise ratio; minimum chromatin input demands and day-to-day variability. Given the strong data generated to date, and the urgent need for an improved ChIP-Seq assay, we have proposed a Direct to Phase II workplan toward the commercialization of this powerful method. The Phase I report provides compelling evidence that the method is a dramatic improvement over existing methods, with Phase II aims focused on manufacturing a kit for the H3K4me3 assay reagents, external validation of this assay and expanding the menu of PTM-specific ICeChIP-Seq reagents to other epigenetic marks.
描述(由申请人提供):染色质免疫沉淀(芯片)是ESSION研究的核心方法之一。芯片数据集。表观遗传标记。条形码序列的条形码设计器核小体是在不同浓度的Ntiboty中添加到碎屑核心的表观遗传标记,并分析了下一代测序数据,用于使用1个条形码的读数和2)。计算每个条形码核体的IP富集到输入浓度,将条形码作为校准剂,它们经历了相同的变异源。 HASS的概念集中在以下内容:核心体的核心核心;迫切需要改进的芯片 - 塞克测定法,我们已经直接向vidence进行了工作平台,即该方法是对现有方法H3K4me3测定试剂的巨大改进 - 其他表观遗传标记的特异性冰氮seq试剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zu-Wen Sun其他文献
Zu-Wen Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zu-Wen Sun', 18)}}的其他基金
Novel recombinant sensors to study histone ubiquitin signaling
研究组蛋白泛素信号传导的新型重组传感器
- 批准号:
10600926 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins
用于测量染色质相互作用蛋白体内活性的快速而稳健的测定
- 批准号:
10759170 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
A novel platform for quantification of acute neuronal transcriptional responses
用于量化急性神经元转录反应的新平台
- 批准号:
10600925 - 财政年份:2022
- 资助金额:
$ 67.66万 - 项目类别:
Engineered super-affinity reagents for detection of histone post-translational modifications
用于检测组蛋白翻译后修饰的工程超亲和力试剂
- 批准号:
10553250 - 财政年份:2022
- 资助金额:
$ 67.66万 - 项目类别:
Engineered super-affinity reagents for detection of histone post-translational modifications
用于检测组蛋白翻译后修饰的工程超亲和力试剂
- 批准号:
10382046 - 财政年份:2022
- 资助金额:
$ 67.66万 - 项目类别:
Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents
基于多重核小体的分析,用于开发下一代染色质标记试剂
- 批准号:
10094217 - 财政年份:2020
- 资助金额:
$ 67.66万 - 项目类别:
Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents
基于多重核小体的分析,用于开发下一代染色质标记试剂
- 批准号:
9911362 - 财政年份:2020
- 资助金额:
$ 67.66万 - 项目类别:
Novel enzyme inhibitor screening platform using modified designer nucleosomes
使用改良设计核小体的新型酶抑制剂筛选平台
- 批准号:
9253050 - 财政年份:2017
- 资助金额:
$ 67.66万 - 项目类别:
Histone phosphorylation-dependent screening platform for identification of inhibitors to treat neuroblastoma
组蛋白磷酸化依赖性筛选平台,用于鉴定治疗神经母细胞瘤的抑制剂
- 批准号:
9201485 - 财政年份:2016
- 资助金额:
$ 67.66万 - 项目类别:
Developing Novel Peptide Arrays for Epigenetic Research
开发用于表观遗传学研究的新型肽阵列
- 批准号:
8715130 - 财政年份:2014
- 资助金额:
$ 67.66万 - 项目类别:
相似国自然基金
地表与大气层顶短波辐射多分量一体化遥感反演算法研究
- 批准号:42371342
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
高速铁路柔性列车运行图集成优化模型及对偶分解算法
- 批准号:72361020
- 批准年份:2023
- 资助金额:27 万元
- 项目类别:地区科学基金项目
随机密度泛函理论的算法设计和分析
- 批准号:12371431
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
基于全息交通数据的高速公路大型货车运行风险识别算法及主动干预方法研究
- 批准号:52372329
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
强磁场作用下两相铁磁流体动力学相场模型的高精度数值算法研究
- 批准号:12361074
- 批准年份:2023
- 资助金额:27 万元
- 项目类别:地区科学基金项目
相似海外基金
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
- 批准号:
10658665 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
项目2:PDAC新抗原疫苗耐药机制
- 批准号:
10708575 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons
研究 RNA 复制子诱导的 SIV/HIV T 和 B 细胞免疫的保护功效
- 批准号:
10673223 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别: